See Shionogi-Sponsored Publications
Publications
Here, you can review available Shionogi-sponsored publications. If you would like an electronic copy of one of the journal publications on this page, please contact
Shionogi Medical Information for further assistance.
Information about investigational compounds or investigational uses of products does not imply FDA approval of these compounds or uses, nor does it establish the safety or efficacy of these compounds or uses. There is no guarantee that the investigational compounds or investigational uses of products will receive FDA approval. Shionogi does not recommend or suggest use of its products in a manner inconsistent with FDA-approved labeling.
Antimicrobial snapshot: cefiderocol
Antimicrobial snapshot: cefiderocol
Cefiderocol activity against multidrug-resistant isolates from the PERSEUS study: relationship between cefiderocol minimum inhibitory concentration and clinical outcomes
Cefiderocol activity against multidrug-resistant isolates from the PERSEUS study: relationship between cefiderocol minimum inhibitory concentration and clinical outcomes
Effects of ensitrelvir on the pharmacokinetics of combined oral contraceptives (ethinyl estradiol/drospirenone) in healthy adult women: a phase 1 fixed-sequence, multiple-dose, drug–drug interaction study
Effects of ensitrelvir on the pharmacokinetics of combined oral contraceptives (ethinyl estradiol/drospirenone) in healthy adult women: a phase 1 fixed-sequence, multiple-dose, drug–drug interaction study
Ensitrelvir for COVID-19 postexposure prophylaxis in household contacts
Ensitrelvir for COVID-19 postexposure prophylaxis in household contacts
Understanding mechanisms of reduced cefiderocol susceptibility in pvdS and fecI mutants of Pseudomonas aeruginosa
Understanding mechanisms of reduced cefiderocol susceptibility in pvdS and fecI mutants of Pseudomonas aeruginosa